Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2011 1
2012 5
2013 3
2014 1
2015 1
2016 8
2017 3
2018 3
2019 9
2020 16
2021 17
2022 11
2023 13
2024 4
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: schafer n. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
Primary CNS lymphoma: a clinician's guide.
Schäfer N, Glas M, Herrlinger U. Schäfer N, et al. Expert Rev Neurother. 2012 Oct;12(10):1197-206. doi: 10.1586/ern.12.120. Expert Rev Neurother. 2012. PMID: 23082736 Review.
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma.
Schneider M, Potthoff AL, Ahmadipour Y, Borger V, Clusmann H, Combs SE, Czabanka M, Dührsen L, Etminan N, Freiman TM, Gerlach R, Gessler F, Giordano FA, Gkika E, Goldbrunner R, Güresir E, Hamou H, Hau P, Ille S, Jägersberg M, Keric N, Khaleghi-Ghadiri M, König R, Konczalla J, Krenzlin H, Krieg S, McLean AL, Layer JP, Lehmberg J, Malinova V, Meyer B, Meyer HS, Miller D, Müller O, Musahl C, Pregler BEF, Rashidi A, Ringel F, Roder C, Rössler K, Rohde V, Sandalcioglu IE, Schäfer N, Schaub C, Schmidt NO, Schubert GA, Seidel C, Seliger C, Senft C, Shawarba J, Steinbach J, Stöcklein V, Stummer W, Sure U, Tabatabai G, Tatagiba M, Thon N, Timmer M, Wach J, Wagner A, Wirtz CR, Zeiler K, Zeyen T, Schuss P, Surges R, Fuhrmann C, Paech D, Schmid M, Borck Y, Pietsch T, Struck R, Radbruch A, Helmstaedter C, Németh R, Herrlinger U, Vatter H. Schneider M, et al. Among authors: schafer n. BMC Cancer. 2025 Feb 20;25(1):306. doi: 10.1186/s12885-025-13682-3. BMC Cancer. 2025. PMID: 39979825 Free PMC article.
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.
Zeyen T, Böhm L, Paech D, Schäfer N, Tzaridis T, Duffy C, Nitsch L, Schneider M, Potthoff AL, Schneider-Rothhaar JL, Steinbach JP, Hau P, Kowalski T, Seidel C, Krex D, Grauer O, Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W, Hattingen E, Glas M, Gkika E, Vatter H, Radbruch A, Herrlinger U, Weller J, Schaub C. Zeyen T, et al. Among authors: schafer n. Neuro Oncol. 2025 Feb 10;27(2):557-566. doi: 10.1093/neuonc/noae205. Neuro Oncol. 2025. PMID: 39351820
Vemurafenib for leptomeningeal melanomatosis.
Schäfer N, Scheffler B, Stuplich M, Schaub C, Kebir S, Rehkämper C, Mack F, Niehusmann P, Simon M, Greschus S, Kuchelmeister K, Herrlinger U, Glas M. Schäfer N, et al. J Clin Oncol. 2013 Apr 10;31(11):e173-4. doi: 10.1200/JCO.2012.46.5773. Epub 2013 Mar 4. J Clin Oncol. 2013. PMID: 23460716 No abstract available.
Five-Fraction Stereotactic Radiotherapy for Brain Metastases-A Retrospective Analysis.
Layer JP, Layer K, Sarria GR, Röhner F, Dejonckheere CS, Friker LL, Zeyen T, Koch D, Scafa D, Leitzen C, Köksal M, Schmeel FC, Schäfer N, Landsberg J, Hölzel M, Herrlinger U, Schneider M, Giordano FA, Schmeel LC. Layer JP, et al. Among authors: schafer n. Curr Oncol. 2023 Jan 17;30(2):1300-1313. doi: 10.3390/curroncol30020101. Curr Oncol. 2023. PMID: 36826062 Free PMC article.
Boswellia serrata for the Management of Radiation-Induced Cerebral Edema and Necrosis: A Systematic Meta-Narrative Review of Clinical Evidence.
Dejonckheere CS, Scafa D, Käsmann L, Zeyen T, Potthoff AL, Schäfer N, Weller J, Herrlinger U, Schneider M, Vatter H, Grosu AL, Brehmer S, Giordano FA, Sarria GR, Gkika E, Layer JP. Dejonckheere CS, et al. Among authors: schafer n. Adv Radiat Oncol. 2025 Feb 1;10(4):101732. doi: 10.1016/j.adro.2025.101732. eCollection 2025 Apr. Adv Radiat Oncol. 2025. PMID: 40092573 Free PMC article. Review.
Distress in Neuro-Oncology Patients and Its Implications for Communication.
Roos C, Weller J, Landwehr C, Sciermoch A, Duffy C, Kohlmann K, Schaub C, Tzaridis T, Schneider M, Schuss P, Herrlinger U, Schäfer N. Roos C, et al. Among authors: schafer n. J Adv Pract Oncol. 2023 May;14(4):292-299. doi: 10.6004/jadpro.2023.14.4.3. Epub 2023 May 1. J Adv Pract Oncol. 2023. PMID: 37313277 Free PMC article.
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Tzaridis T, Weller J, Bachurski D, Shakeri F, Schaub C, Hau P, Buness A, Schlegel U, Steinbach JP, Seidel C, Goldbrunner R, Schäfer N, Wechsler-Reya RJ, Hallek M, Scheffler B, Glas M, Haeberle L, Herrlinger U, Coch C, Reiners KS, Hartmann G. Tzaridis T, et al. Among authors: schafer n. Int J Cancer. 2023 Jan 15;152(2):308-319. doi: 10.1002/ijc.34261. Epub 2022 Sep 17. Int J Cancer. 2023. PMID: 36054558
91 results